Literature DB >> 17027517

The interleukin-1 receptor family.

Diana Boraschi1, Aldo Tagliabue.   

Abstract

The cytokines IL-1 and IL-18 are key molecules both in the innate and in the adaptive immune response. Their activity is mediated by specific receptors present on the membrane of target cells. It has become apparent that these receptors are members of a larger family of related receptors, most of which are apparently involved in the mechanisms of host defense. Thus, the large Toll/IL-1R (TIR) superfamily encompasses the Ig domain family (IL-1 receptors, IL-18 receptors, and IL-1R-like receptors), the leucine-rich domain family [the Toll-like receptors (TLR) and similar receptors], and a series of TIR domain-containing intracellular adapter molecules. The TIR superfamily is defined by a common intracellular TIR domain, involved in the initiation of signaling. A group of TIR domain-containing adapters (MyD88, TIRAP, TRIF, and TRAM) are differentially recruited to the Toll/IL-1 receptors, contributing to the specificity of signaling. Recent studies have also begun to unravel the mechanisms of negative regulation of the Toll/IL-1 receptors. The orphan receptor TIR8/SIGIRR, a member of TIR superfamily, while unable to initiate signaling, can negatively modulate the TIR-mediated responses. Other negative regulators of the Toll/IL-1R family include T1/ST2, some soluble forms of TLR, and MyD88s. The coordinated positive and negative regulation of the TIR activation ensures the appropriate modulation of the innate and inflammatory responses and avoids the risk of pathological derangement. This chapter will consider in detail the characteristics and functional role of the Ig domain receptor subfamily in the regulation of host defense and their possible role in pathology.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027517     DOI: 10.1016/S0083-6729(06)74009-2

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  44 in total

Review 1.  The amphioxus genome provides unique insight into the evolution of immunity.

Authors:  Larry J Dishaw; Robert N Haire; Gary W Litman
Journal:  Brief Funct Genomics       Date:  2012-03-07       Impact factor: 4.241

Review 2.  Hypothalamic mechanisms in cachexia.

Authors:  Aaron J Grossberg; Jarrad M Scarlett; Daniel L Marks
Journal:  Physiol Behav       Date:  2010-03-25

Review 3.  Cytokine-receptor interactions as drug targets.

Authors:  Gideon Schreiber; Mark R Walter
Journal:  Curr Opin Chem Biol       Date:  2010-07-07       Impact factor: 8.822

4.  Down-regulation of single immunoglobulin interleukin-1R-related molecule (SIGIRR)/TIR8 expression in intestinal epithelial cells during inflammation.

Authors:  C Kadota; S Ishihara; M M Aziz; M A Rumi; N Oshima; Y Mishima; I Moriyama; T Yuki; Y Amano; Y Kinoshita
Journal:  Clin Exp Immunol       Date:  2010-11       Impact factor: 4.330

Review 5.  IL-1 pathways in inflammation and human diseases.

Authors:  Cem Gabay; Céline Lamacchia; Gaby Palmer
Journal:  Nat Rev Rheumatol       Date:  2010-02-23       Impact factor: 20.543

6.  The amphioxus genome illuminates vertebrate origins and cephalochordate biology.

Authors:  Linda Z Holland; Ricard Albalat; Kaoru Azumi; Elia Benito-Gutiérrez; Matthew J Blow; Marianne Bronner-Fraser; Frederic Brunet; Thomas Butts; Simona Candiani; Larry J Dishaw; David E K Ferrier; Jordi Garcia-Fernàndez; Jeremy J Gibson-Brown; Carmela Gissi; Adam Godzik; Finn Hallböök; Dan Hirose; Kazuyoshi Hosomichi; Tetsuro Ikuta; Hidetoshi Inoko; Masanori Kasahara; Jun Kasamatsu; Takeshi Kawashima; Ayuko Kimura; Masaaki Kobayashi; Zbynek Kozmik; Kaoru Kubokawa; Vincent Laudet; Gary W Litman; Alice C McHardy; Daniel Meulemans; Masaru Nonaka; Robert P Olinski; Zeev Pancer; Len A Pennacchio; Mario Pestarino; Jonathan P Rast; Isidore Rigoutsos; Marc Robinson-Rechavi; Graeme Roch; Hidetoshi Saiga; Yasunori Sasakura; Masanobu Satake; Yutaka Satou; Michael Schubert; Nancy Sherwood; Takashi Shiina; Naohito Takatori; Javier Tello; Pavel Vopalensky; Shuichi Wada; Anlong Xu; Yuzhen Ye; Keita Yoshida; Fumiko Yoshizaki; Jr-Kai Yu; Qing Zhang; Christian M Zmasek; Pieter J de Jong; Kazutoyo Osoegawa; Nicholas H Putnam; Daniel S Rokhsar; Noriyuki Satoh; Peter W H Holland
Journal:  Genome Res       Date:  2008-06-18       Impact factor: 9.043

7.  Regulating human Th17 cells via differential expression of IL-1 receptor.

Authors:  Won-Woo Lee; Seong Wook Kang; Jihoon Choi; Seung-Hyun Lee; Kamini Shah; Elizabeth E Eynon; Richard A Flavell; Insoo Kang
Journal:  Blood       Date:  2009-11-12       Impact factor: 22.113

8.  Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes.

Authors:  Andreas Lingel; Thomas M Weiss; Marc Niebuhr; Borlan Pan; Brent A Appleton; Christian Wiesmann; J Fernando Bazan; Wayne J Fairbrother
Journal:  Structure       Date:  2009-10-14       Impact factor: 5.006

9.  MyD88-deficient mice exhibit decreased parasite-induced immune responses but reduced disease severity in a murine model of neurocysticercosis.

Authors:  Bibhuti B Mishra; Uma Mahesh Gundra; Kondi Wong; Judy M Teale
Journal:  Infect Immun       Date:  2009-09-28       Impact factor: 3.441

Review 10.  The IL-33/ST2 pathway: therapeutic target and novel biomarker.

Authors:  Rahul Kakkar; Richard T Lee
Journal:  Nat Rev Drug Discov       Date:  2008-10       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.